Cargando…

Usefulness of real-time PCR during follow-up of patients treated with Benznidazole for chronic Chagas disease: Experience in two referral centers in Barcelona

BACKGROUND: Antitrypanosomal treatment with Benznidazole (BZ) or Nifurtimox may be recommended for patients with chronic Chagas disease (CD) to reduce the onset or progression of symptoms. However, such treatment has limited efficacy and high level of toxic effects. In addition, the current cure bio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sulleiro, Elena, Silgado, Aroa, Serre-Delcor, Núria, Salvador, Fernando, Tavares de Oliveira, Maykon, Moure, Zaira, Sao-Aviles, Augusto, Oliveira, Inés, Treviño, Begoña, Goterris, Lidia, Sánchez-Montalvá, Adrián, Pou, Diana, Molina, Israel, Pumarola, Tomàs
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048293/ https://www.ncbi.nlm.nih.gov/pubmed/32069287 http://dx.doi.org/10.1371/journal.pntd.0008067

Ejemplares similares

Opportunistic Community Screening of Chronic Chagas Disease Using a Rapid Diagnosis Test in Pharmacies in Barcelona (Catalonia, Spain): Study Protocol and Pilot Phase Results
por: Silgado, Aroa, et al.
Publicado: (2022)

Analytical Evaluation of Dried Blood Spot and Rapid Diagnostic Test as a New Strategy for Serological Community Screening for Chronic Chagas Disease
por: Silgado, Aroa, et al.
Publicado: (2021)

Changes in the microbiological diagnosis and epidemiology of cutaneous leishmaniasis in real-time PCR era: A six-year experience in a referral center in Barcelona
por: Silgado, Aroa, et al.
Publicado: (2021)

Intra-Discrete Typing Unit TcV Genetic Variability of Trypanosoma cruzi in Chronic Chagas' Disease Bolivian Immigrant Patients in Barcelona, Spain
por: de Oliveira, Maykon Tavares, et al.
Publicado: (2021)

Quantification of parasite burden of Trypanosoma cruzi and identification of Discrete Typing Units (DTUs) in blood samples of Latin American immigrants residing in Barcelona, Spain
por: Tavares de Oliveira, Maykon, et al.
Publicado: (2020)

Evaluation of Two Different Strategies for Schistosomiasis Screening in High-Risk Groups in a Non-Endemic Setting
por: Roade, Luisa, et al.
Publicado: (2023)

A retrospective study on the influence of siblings’ relatedness in Bolivian patients with chronic Chagas disease
por: Espinosa-Pereiro, Juan, et al.
Publicado: (2019)

Benznidazole, itraconazole and their combination in the treatment of acute experimental Chagas disease in dogs
por: Cunha, Eleonora Lima Alves, et al.
Publicado: (2019)

Unexpected Loa loa Finding in an Asymptomatic Patient From The Gambia: A Case Report
por: Treviño, Begoña, et al.
Publicado: (2023)

Chagas Cardiomyopathy: Usefulness of EKG and Echocardiogram in a Non-Endemic Country
por: Sánchez-Montalvá, Adrián, et al.
Publicado: (2016)

Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B
por: Ubals, Maria, et al.
Publicado: (2021)

From Benznidazole to New Drugs: Nanotechnology Contribution in Chagas Disease
por: Gomes, Daniele Cavalcante, et al.
Publicado: (2023)

Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease
por: de Oliveira-Silva, Jaquelline Carla Valamiel, et al.
Publicado: (2015)

COVID-19: an opportunity of systematic integration for Chagas disease. Example of a community-based approach within the Bolivian population in Barcelona
por: Gómez i Prat, Jordi, et al.
Publicado: (2022)

Epidemiological and clinical profile of adult patients with Blastocystis sp. infection in Barcelona, Spain
por: Salvador, Fernando, et al.
Publicado: (2016)

Benznidazole Use among Patients with Chronic Chagas' Cardiomyopathy in an Endemic Region of Brazil
por: Ferreira, Ariela Mota, et al.
Publicado: (2016)

Population pharmacokinetic modeling of benznidazole in Brazilian patients with chronic Chagas disease
por: Frade, Virgínia Paula, et al.
Publicado: (2022)

Microscopic examination after concentration techniques for Blastocystis sp. detection in serial faecal samples: How many samples are needed?
por: Not, Anna, et al.
Publicado: (2020)

Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II superiority clinical trial
por: Molina-Morant, D., et al.
Publicado: (2020)

Zika Virus Infection in Tourists Travelling to Thailand: Case Series Report
por: Romaní, Natàlia, et al.
Publicado: (2020)

Hantavirus Pulmonary Syndrome in Traveler Returning from Nepal to Spain
por: Sulleiro, Elena, et al.
Publicado: (2020)

Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study
por: Cardoso, Clareci Silva, et al.
Publicado: (2018)

Impact of Helminth Infection on the Clinical and Microbiological Presentation of Chagas Diseases in Chronically Infected Patients
por: Salvador, Fernando, et al.
Publicado: (2016)

A case report of long treatment with Itraconazole in a patient with chronic Chagas disease
por: Bosch-Nicolau, Pau, et al.
Publicado: (2019)

Hepatic changes by benznidazole in a specific treatment for Chagas disease
por: Pavan, Tycha Bianca Sabaini, et al.
Publicado: (2018)

Access to benznidazole for Chagas disease in the United States—Cautious optimism?
por: Alpern, Jonathan D., et al.
Publicado: (2017)

Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas’ disease
por: Jackson, Yves, et al.
Publicado: (2020)

Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease
por: Rolon, Miriam, et al.
Publicado: (2022)

Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
por: Vázquez, Cristina, et al.
Publicado: (2023)

Correction: Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial
por: Molina-Morant, D., et al.
Publicado: (2023)

Neurological Short-Term Outcomes of a Cohort of Children Born to Zika Virus-Infected Mothers in Barcelona
por: Romaní, Natàlia, et al.
Publicado: (2022)

The fecal, oral, and skin microbiota of children with Chagas disease treated with benznidazole
por: Robello, Carlos, et al.
Publicado: (2019)

Benznidazole and Posaconazole in Experimental Chagas Disease: Positive Interaction in Concomitant and Sequential Treatments
por: Diniz, Lívia de Figueiredo, et al.
Publicado: (2013)

Evaluation of Parasiticide Treatment with Benznidazol in the Electrocardiographic, Clinical, and Serological Evolution of Chagas Disease
por: Fragata-Filho, Abilio Augusto, et al.
Publicado: (2016)

Correction: The fecal, oral, and skin microbiota of children with Chagas disease treated with benznidazole
por: Robello, Carlos, et al.
Publicado: (2019)

Access to Chagas disease treatment in the United States after the regulatory approval of benznidazole
por: Yoshioka, Kota, et al.
Publicado: (2020)

Characterization of adverse reactions to benznidazole in patients with Chagas disease in the Federal District, Brazil
por: Gontijo, Maria Katarine Costa Lucas, et al.
Publicado: (2020)

Imported strongyloidiasis: Data from 1245 cases registered in the +REDIVI Spanish Collaborative Network (2009-2017)
por: Salvador, Fernando, et al.
Publicado: (2019)

Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display
por: Rodriguez Carnero, Luis Antonio, et al.
Publicado: (2023)

Viral populations of SARS-CoV-2 in upper respiratory tract, placenta, amniotic fluid and umbilical cord blood support viral replication in placenta
por: Piñana, Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l25fu0er417crrfck7rrs43d1u